Contribuição à terapêutica do mal perfurante plantar: tratamento pela leprolina "Souza-Araujo" em injeções intra-ulcerosas

The writer, as medical director of Father Damien Leper Colony (Ubá, Minas Gerais, Brasil), treated 50 cases of perforating ulcers, from 2 to 40 years of duration, using the antigens prepared with acid-fast bacilli cultures obtained from leprous material by Dr. H. C. de Souza-Araujo. Dosage from 0,12 to 39,35 cm3, injected inside the ulcers, intramuscularly, every 2 to 4 days, accordingly to the patient reaction some of them presenting fever until 41° Centigrade. The result was cicatrization of the ulcers in 92% (46 out of 50) of the patients. The author concluded that the majority of his patients tolerate perfectly the medicine and that its efect was very eficient.

A study of aspects of heterokaryosis in aspergillus nidulans

A series of studies have been undertaken to find cases in which heterokaryons show adaptative response to environmental change. Comparisons have also been made between the phenotypes of heterokaryons and corresponding heterozygotes. Unsuccessful attempts were made to produce heterokaryons, on complete medium, balanced by one previously-existing mutant and one newly-obtained slow-growing mutant. Adaptation was achieved in heterokaryons carrying different mutant alleles conferring resistance to: (a) acriflavine, (b) actidione and (c) p-fluorophenylalanine. Comparison with the heterozygote in case (a) suggested a highly localised action of the allele determining resistance. A similar comparison for (b) suggested a non-localised action. In cases (b) and (c) dosage effects were observed in the degree of resistance that the heterokaryons, compared with the corresponding heterozygotes, could achieve. In case (c) interaction of the resistance marker with a nutritional marker (nic8) has been investigated further and a new unteraction between nic8 and Act1 detected. During this work a new conidial colour mutant, fawn, was isolated and characterised. It is likely to be a valuable visual marker, especially in view of its interaction with other colour mutants.

Esquistossomose mansoni: tratamento medicamentoso

It is the specific treatment of mansoni schistosomiasis that aims to act directed on the parasite, through chemotherapy. Constitutes fundamental indication to the treatment of schistosomiasis active forms, that is, these determined by the presence of living eggs in the feces or in material from rectal biopsy, since eventual contra indications are respected. Two are the medicaments actually used: oxamniquine, used in the single dosage of 15mg/kg, V.O. for adults and 20mg/kg V.O. for children divided in two doses, offers a percentage of 30 to 40% of cures, evaluated by quantitative "oogram" and prazinquantel, in the single dose of 60 mg/kg V.O., presents a cure index of 30% however in seriate doses, of 60mg/kg during 3 days or 30mg/kg, 6 days, cure percentage is elevated to 95% evaluated by oogram. The evaluation of the treatment by quantitative or qualitative examination methods does not show the same sensibility. The percentage of cure according to feces examination, the quantitative of Kato-Katz or the qualitative (sedimentation), showed indexes from 90 to 100% for either one of the drugs, even in single dose, which evidences the difference of methodology of therapeutic evaluation. Tolorance to both medicaments is from good to regular, with collateral effects in 30 to 40% of the patients.

Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents

The susceptibility of four isolates of Schistosoma mansoni (BH, MAP, MPR-1 and K) to four multiple doses of anti-schistosomal agents (hycanthone, niridazole, oxamniquire, and praziquantel) were evaluated in infected female Swiss albino mice. These schistosomal isolates had been maintained in the laboratory without further drug pressure for 20 to 30 generations. Multiple dosage regimens were used for each drug against each isolate of S. mansoni to generate ED50 (effective dose 50%) values. Results demonstrated that the K isolate is resistant to niridazole, the MPR-1 isolate to oxamniquine, and the MAP isolate to both hycanthone and oxamniquine. The BH isolate was susceptible to all drugs and was used as the reference isolate. All isolates were susceptible to praziquantel. The significance of the difference in response of the MPR-1 and MAP isolates is discussed. These results confirm the resistance of these isolates of S. mansoni of three schistosomicides and demonstrate that the resistance of these isolates are stable over long periods of time without exposure to drugs.